CSIMarket
 


Gamida Cell Ltd   (GMDA)
Other Ticker:  
 
 

GMDA's EPS from Cont. Operations Growth by Quarter and Year

Gamida Cell Ltd 's EPS from Cont. Operations results by quarter and year




GMDA EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.30 0.00 0.00
III Quarter September 0.01 0.29 0.00 0.00
II Quarter June 0.31 0.31 0.00 0.00
I Quarter March 0.27 0.34 0.00 0.00
FY   0.59 1.24 0.00 0.00



GMDA EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment
Gamida Cell Ltd reported drop in EPS from Cont. Operations in the third quarter 2023 by -96.55% to $ 0.01 , from the same quarter in 2022.
This represents worst decline in recent Company history.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher EPS from Cont. Operations growth. While Gamida Cell Ltd ' s EPS from Cont. Operations meltdown of -96.55% ranks overall at the positon no. 2005 in the third quarter 2023.




GMDA EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September -96.55 % - - -
II Quarter June 0 % - - -
I Quarter March -20.59 % - - -
FY   - - - -

Financial Statements
Gamida Cell Ltd 's third quarter 2023 EPS from Cont. Operations $ 0.01 GMDA's Income Statement
Gamida Cell Ltd 's third quarter 2022 EPS from Cont. Operations $ 0.29 Quarterly GMDA's Income Statement
New: More GMDA's historic EPS from Cont. Operations Growth >>


GMDA EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 3.45 % - -
III Quarter September -96.77 % -6.45 % - -
II Quarter June 14.81 % -8.82 % - -
I Quarter March -10 % - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #122
Overall #2005

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % -39.05 % -96.55 %
(Jun 30 2023)   (Sep 30 2023)
EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #122
Overall #2005
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % -39.05 % -96.55 %
(Jun 30 2023)   (Sep 30 2023)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Gamida Cell Ltd 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
14.81 % -17.29 % -96.77 %
(Jun 30 2023)  


GMDA's III. Quarter Q/Q EPS from Cont. Operations Comment
In the III. Quarter 2023 Gamida Cell Ltd realized fall in EPS from Cont. Operations sequentially by -96.77% to $ 0.01 , from $ 0.31 achived in the previous reporting period.

If you look into present downturn in the III. Quarter 2023, you should take into consideration, that commonly III. Quarter EPS from Cont. Operations occur sluggish then in the preciding period

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Gamida Cell Ltd 's EPS from Cont. Operations growth quarter on quarter, overall rank is 2086.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #126
Overall #2086
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #126
Overall #2086
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
14.81 % -17.29 % -96.77 %
(Jun 30 2023)  


GMDA's III. Quarter Q/Q EPS from Cont. Operations Comment
In the III. Quarter 2023 Gamida Cell Ltd realized fall in EPS from Cont. Operations from the previous quarter by -96.77% to $ 0.01 , from $ 0.31 achived in the previous quarter.

It's not big issue, as Gamida Cell Ltd 's EPS from Cont. Operations frequently gravitate to slow in this quarter.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Gamida Cell Ltd 's EPS from Cont. Operations growth quarter on quarter, overall rank is 2086.


Gamida Cell Ltd 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.89 $ 1.17 $ 1.17 $ 1.24 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) -23.92 % 0 % -5.64 % - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking #